<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

1 min read

Advanced Therapies Europe, Aug 30 - Sep 1, 2022

Advanced Therapies Europe, Aug 30 - Sep 1, 2022

Date: August 30 - September 1, 2022
Location: Royal Lancaster London
Event Website: https://advancedtherapieseurope.phacilitate.com
Organizer: Phacilitate

Meet with our Team Members

 

Contact us to schedule a meeting

About our Cell & Gene Therapy Services

We develop and manufacture diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, depending on client needs. We also develop and manufacture adeno-associated viral vectors, lenti viral vectors and retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. 

Learn more about our Cell Therapy and Viral Vector services

About the Event

Advanced Therapies Europe promises to educate and inspire advanced therapies professionals currently working in Europe, as well as those that are looking to enter into the European market.

Advanced Therapies Europe is tailored to a European audience looking to commercialize ATMPs globally, as well as a global audience looking to understand and expand into the European market. By bringing these two groups together, new partnerships can be forged to solidify Europe as a hub for cell and gene therapy.

ASGCT Annual Meeting, May 7-11

ASGCT Annual Meeting, May 7-11

CPHI Japan, April 17-19

CPHI Japan, April 17-19

German Biotech Days. April 16-17

German Biotech Days. April 16-17